Bostonians Walk, Run for Kids with Brain Tumors

About 200 Bostonians gathered on Sept. 26 for the Starry Night Boston 8.5K, benefiting the Pediatric Brain Tumor Foundation. At start time, the event had raised $27,074 to help fund the foundation’s lifesaving research and life-changing family support programs. The crowd gathered for the... - September 30, 2015 - Pediatric Brain Tumor Foundation

Motorcyclists Contribute $167,000 to Aid Sick Children

From the Las Vegas Strip to the Capitol area, more than 700 motorcyclists gathered for children battling brain tumors over the weekend. As of ride time, the family-friendly Baltimore-Washington and Las Vegas Ride for Kids events had raised $167,459 to support the Pediatric Brain Tumor... - September 30, 2015 - Pediatric Brain Tumor Foundation

Ixogel® is Granted QIDP Status by the US Food and Drug Administration

Ixodes AG, a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention of Lyme Disease, today announced that the U.S. Food and Drug Administration (FDA) has designated the company's lead product candidate, Ixogel®, as a Qualified Infectious Disease Product (QIDP) for the prevention of Lyme Disease after a tick bite and is working with the company on the phase III protocol. Special Protocol Assessment (SPA) confirmation expected soon. - September 29, 2015 - Ixodes AG

Bioo Scientific Releases Automated Small RNA Library Prep Protocol for the Sciclone NGS Workstation

Bioo Scientific has automated bias-reducing small RNA library prep on the Sciclone® NGS and NGSx Workstations, automating the NEXTflex™ Small RNA-Seq Library Prep Kit v2 and increasing productivity by reducing the time and labor costs associated with small RNA library prep. - September 26, 2015 - Bioo Scientific

FDA Renews Pinnacle 21 as Software Provider for DataFit

Pinnacle 21 announced today that it has been selected to provide custom software and related services to support the FDA’s DataFit program, which serves to expedite the new drug application process. - September 26, 2015 - Pinnacle 21

Bioo Scientific Showcases Innovative Solutions for Rapid Food Safety Testing at AOAC 2015

Bioo Scientific will exhibit its latest advances in food and feed safety and quality testing, at booth #502 of the 129th AOAC Annual Meeting, September 27-30 in Los Angeles, CA. New technologies include the most sensitive test available for histamine screening, a sulfite detection method which overcomes issues with problematic “high-creep” samples, optimized immunoaffinity columns for mycotoxin analysis, and a solution for high-throughput detection of amantadine residues in poultry. - September 25, 2015 - Bioo Scientific

MoBiTec GmbH to Attend BIOTECHNICA 2015, Germany - See ZDGSY's Inimitable GS-Key, an Amazingly Small and Fast DNA Extraction Device

BIOTECHNICA - Europe's No.1 Event for Biotechnology, Life Sciences, and Lab Technology! At MoBiTec's booth, cutting-edge technologies will be presented. Highlight: An incredibly small and fast handheld device for DNA extraction! - September 25, 2015 - MoBiTec GmbH

Philadelphia Athletes Complete 8.5k for Kids with Brain Tumors

The City of Brotherly Love welcomed about 750 walkers and runners on Sept. 19 for the Philadelphia Starry Night 8.5K, benefiting the Pediatric Brain Tumor Foundation. At start time, the event had raised $47,974 to help fund the foundation’s lifesaving research and life-changing family... - September 23, 2015 - Pediatric Brain Tumor Foundation

Golden State Motorcyclists Ride for Kids with Brain Tumors

More than 330 motorcyclists gathered for children battling brain tumors at the San Diego Ride for Kids event over the weekend. As of ride time, this motorcycle event had raised $35,912 to support the Pediatric Brain Tumor Foundation. The event at Mira Costa College in Cardiff honored four local... - September 23, 2015 - Pediatric Brain Tumor Foundation

Bioo Scientific Launches Enzymatic Assay for Accurate Homocysteine Analysis in Model Organisms

Bioo Scientific has released the MaxDiscovery™ Homocysteine Enzymatic Assay Kit. This kit uses a new enzymatic technology for spectrophotometric detection of total homocysteine levels in serum from rodents and other mammals. This kit enables the determination of hyperhomocysteinemia, or elevated levels of total homocysteine (tHcy) in the blood, which is an independent risk factor for neural tube defects, vascular diseases and Alzheimer’s disease, and other diseases. - September 23, 2015 - Bioo Scientific

Marriage of Science and Marketing Makes Beautiful Skin Affordable

Marriage of Science and Marketing Makes Beautiful Skin Affordable

RxGenesys blends high-end stem cell tech with smart distribution and devoted customers to bring celebrity beauty secrets to real women -- on a budget. Less than three minutes and $1.50 a day visibly improve the skin’s appearance. When Sports Illustrated goddess Paulina Porizkova burst onto... - September 21, 2015 - RxGenesys

Miami-Based RxGenesys, LLC Raises 4 Million in Series B Funding

Miami-Based RxGenesys, LLC Raises 4 Million in Series B Funding

With funding and proven results, RxGenesys has partnered with marketing mogul and Shark Tank celebrity Kevin Harrington, who will spearhead the company’s Direct Response Campaign. “I’ve seen a lot of products and a lot of business plans, I joined the RxGenesys initiative because a direct response strategy using a prestige product like this is fresh and absolutely ideal to capture the growing market for products that look and feel like a celebrity insider secret,” Harrington said. - September 21, 2015 - RxGenesys

Experiments to Boost Procyrion's Micro Heart Pump Presented at Scientific Conference

enmodes GmbH, a German company that designs and engineers innovative medical designs, put Houston-based Procyrion Inc.’s Aortix™ micro heart pump through a series of computational fluid dynamic simulations to improve the overall design and performance of the prototype in preparation for... - September 19, 2015 - Procyrion Inc

MoBiTec to Offer ProteoGREEN™-gGlu, a Fluorogenic Probe for Specific Detection of Cancer Cells

ProteoGREEN™-gGlu is a cancer-selective fluorogenic imaging probe that is rapidly activated to a highly fluorescent compound. The membrane-permeable dye is suitable for live cells or in vivo imaging of cancer cells. - September 18, 2015 - MoBiTec GmbH

MD Anderson, Cayman Chemical, and Fannin Innovation Studio Form Therapeutics Company

The University of Texas MD Anderson Cancer Center, Cayman Chemical and Fannin Innovation Studio have formed ACF Pharmaceuticals, LLC. The pre-clinical therapeutics company is dedicated to discovering and developing novel small molecule inhibitors for the treatment of a variety of... - September 17, 2015 - Cayman Chemical Company

Motorcyclists from Coast to Coast Ride for Kids with Brain Tumors

Motorcyclists from Birmingham, Philadelphia and Puget Sound hit the road for children battling brain tumors during Ride for Kids events over the weekend. These family-friendly motorcycle events, held in Leeds, Ala., Phoenixville, Pa., Carnation, Wash., raised more than $150,000 to support the... - September 16, 2015 - Pediatric Brain Tumor Foundation

Novatein Biosciences (NovaTeinBio.com) Launches Food ELISA Kits

Novatein Biosciences (www.novateinbio.com) continues to expand its product line with the launch of food ELISA kits. - September 12, 2015 - Novatein Biosciences

Cayman Chemical and the University of Michigan Issued US Patent for SAM-Screener™ Epigenetic Methylation Test

The United States Patent and Trademark Office has issued a patent to Cayman Chemical and the University of Michigan claiming detection analyte probes based on a natural product mimic of the methyltransferase cofactor S-adenosylmethionine (SAM). Aptly named SAM-Screener™, these probes are the foundation of Cayman’s high-throughput, one-step florescent binding assays for identification of SAM-competitive methyltransferase inhibitors from small-molecule chemical libraries. - September 10, 2015 - Cayman Chemical Company

Bioo Scientific Receives USDA Approval for Using Its ELISA to Screen Meat for Ractopamine Residues

Bioo Scientific’s MaxSignal® Ractopamine ELISA Test Kit has been approved by the USDA for the verification testing requirements for screening of meat in the Quality System Verification Program (QSVP), Never Fed Beta-Agonists Marketing Program. The kit enables the detection of as little as 0.1 ppb of ractopamine in pork and other meat samples, well below the 1 ppb minimal required performance limit used by many countries. - September 04, 2015 - Bioo Scientific

NASH Drugs Market, 2015-2025

The "NASH Drugs Market, 2015-2025" report provides a comprehensive study on the current landscape and the future outlook of the evolving pipeline of molecules in this area. With an expanding NAFLD and NASH population worldwide, there is a growing need for development of therapeutics in this disease area. - September 03, 2015 - Roots Analysis

Protein Expression Systems Market: Current Landscape and Future Opportunities

Advances in genetic engineering and cloning techniques have allowed isolation and expression of heterologous and recombinant proteins for research, therapeutic and industrial uses. Large scale applications such as enzyme, antibody or vaccine production require high amounts of protein. This demands that the system producing protein must be easy to culture, allow rapid cell growth and provide good yield. - September 02, 2015 - Roots Analysis

NanoCellect and UCSD Team Up on Single-Cell Sorting and Analysis

NanoCellect Biomedical, a developer of affordable and accessible flow cytometry and cell sorting technology for life science researchers, begins a collaboration with UCSD to develop single cell applications based on their WOLF Cell Sorter. The WOLF Cell Sorter enables easy-to-use cell sorting that... - September 02, 2015 - NanoCellect

VIRUN® NutraBIOsciences™ Relocates R&D to Pomona, Presenting at Upcoming Cognitive Health Online Summit, Exhibiting at SupplySideWest & Announces VIRUN T-Shirt Trend

VIRUN® NutraBIOsciences™ Relocates R&D to Pomona, Presenting at Upcoming Cognitive Health Online Summit, Exhibiting at SupplySideWest & Announces VIRUN T-Shirt Trend

The Cognitive Health Online Summit will occur on September 2, 2015, and will feature Philip Bromley discussing Smart Delivery Technologies. VIRUN signs a lease for a new R&D facility in Pomona, California. SupplySide West Expo 2015 is right around the corner, and VIRUN is sure to be a crowd pleaser as it goes back in time to deliver the future of functional beverages. VIRUN has added a “Shop VIRUN” page to proliferate the VIRUN phenomenon. - September 01, 2015 - VIRUN

Epitope Diagnostics Introduces Novel Fecal NGAL Specific ELISA Kit for Inflammatory Bowel Disease

Epitope Diagnostics introduces its novel fecal neutrophil gelatinase-associated lipocalin (NGAL) ELISA kit. This is the first commercial kit that is developed for measurement of NGAL levels in human stool sample. Fecal NGAL is potentially a better marker than those currently used in clinical practice. - September 01, 2015 - Epitope Diagnostics, Inc.

KinderPharm LLC Acquires Clinical Pharmacology and Pharmacometric Research and Development Company

KinderPharm LLC., announced that it has acquired PKPD Bioscience, Inc., a clinical pharmacology and pharmacometric research and development company. The purchase will strengthen the capabilities of KinderPharm LLC to provide pediatric PK/PD modeling and simulation as well as Pop PK and sparse sampling. - September 01, 2015 - KinderPharm LLC

Keynote Line-Up and Seven FDA Speakers Confirmed for Immunogenicity and Bioassay Summit 2015, Organized by Cambridge Healthtech Institute

Seventh annual event to focus on technologies and strategies for safe and efficacious products in the clinic. - August 31, 2015 - Cambridge Healthtech Institute

Bioo Scientific Honored for Increasing Austin’s Ability to Compete in the Global Marketplace

Bioo Scientific, an Austin-based biotech company which manufactures food and feed safety test kits and products supporting life science research, received the British Airways International Trade, Investment & Expansion Award, which recognizes investments by international companies in Austin that create jobs locally, as well as Austin-based companies who have a global impact through products and services provided worldwide. - August 30, 2015 - Bioo Scientific

Bioo Scientific Enables the Sensitive Detection of a Broad Range of Beta-Lactam Antibiotics in Food

Bioo Scientific’s MaxSignal® Beta-Lactam ELISA Test Kit has been validated for the screening of a wide range of beta-lactam antibiotics in a number of food matrices, with detection limits as low as 0.8 ppb. - August 27, 2015 - Bioo Scientific

Ambu Partners with ValueCentric in Data Enhancement Initiative

Ambu chooses ValueCentric for their expertise in data cleansing and enhanced Master Data Management services. - August 27, 2015 - ValueCentric

New England, North Carolina Motorcyclists Hit Road for Kids

From the mountains of North Carolina to history-rich sites of Massachusetts, motorcyclists hit the road over the weekend for kids battling brain tumors. These family-friendly Ride for Kids events, held in Asheville, N.C., and Framingham, Mass., raised $84,236 to support the Pediatric Brain Tumor... - August 27, 2015 - Pediatric Brain Tumor Foundation

ALPCO Releases New STELLUX® Chemiluminescent Adiponectin ELISAs

ALPCO Releases New STELLUX® Chemiluminescent Adiponectin ELISAs

ALPCO has launched its new STELLUX® Chemiluminescent Total Adiponectin and HMW Adiponectin ELISAs. - August 25, 2015 - ALPCO

DaVinci Biosciences Announces Publication of "Mesenchymal Stem Cells for the Treatment of Arthritis" in the Book Anti-Aging Therapeutics, Volume 17

DaVinci Biosciences, LLC, a company committed to improving the quality of life for those suffering from degenerative diseases, announced today that the Vice President of Research and Development, Rafael Gonzalez’s, paper “Mesenchymal Stem Cells for the Treatment of Arthritis” has... - August 25, 2015 - DaVinci Biosciences LLC

Molecular Innovations, Inc. Issued U.S. Patent for Human Prorenin ELISA Kit

Molecular Innovations, Inc. has been issued United States Patent Number 9,085,795 for its unique and novel “Human Prorenin ELISA Kit.” - August 23, 2015 - Molecular Innovations

AdvantaPure(R) Welcomes Mark Mistretta as East Coast Sales Manager; Brings Sales and Engineering Experience to Assist Customers with Process System Integration

AdvantaPure announces the appointment of Mark Mistretta to its team. Mistretta fills the east coast sales position vacated due to the recent promotion of another team member. His experience in sales and mechanical engineering will help AdvantaPure’s Single-Use system customers work out their biopharma fluid flow concepts and application challenges. As Eastern Regional Sales Manager, Mistretta is responsible for the management and growth of accounts in the eastern U.S. - August 21, 2015 - AdvantaPure

St. Louis Motorcyclists Rev It Up at Ride for Kids

St. Louis motorcyclists gathered over the weekend to honor 11 local brain tumor survivors at the Pediatric Brain Tumor Foundation's Ride for Kids event. The family-friendly event, held at St. Charles Community College in Cottleville, raised $46,290 to support the foundation's lifesaving research... - August 19, 2015 - Pediatric Brain Tumor Foundation

Concept Life Sciences Acquires CXR Biosciences to Augment Its Expanding Service Base in Discovery and PreClinical Sciences

Concept Life Sciences, scientific Laboratory and consultancy group has acquired CXR Biosciences. This marks its fourth acquisition since it was formed in July 2014. Led by Executive Chairman Michael Fort and Chief Executive Officer Alan Morgan the Concept Life Sciences Group currently has over 600... - August 18, 2015 - Concept Life Sciences

NanoHybrids Launches Gold Nanoparticles Custom Designed to Improve Lateral Flow Quality and Reproducibility

Careful selection of indicator particles is absolutely critical to the performance of any lateral flow assay. NanoHybrids’ new line of monodisperse gold nanoparticles can enable the development of lateral flow assays that meet the highest specifications of the industry, particularly with respect to sensitivity and reproducibility. - August 16, 2015 - NanoHybrids

Eurogentec (EGT), Belgium, Appoints MoBiTec GmbH as Distributor for Germany

Eurogentec (EGT) is a leading provider of innovative products and services to the life science, diagnostic, and pharmaceutical community. MoBiTec is selling the products of AnaSpec, which now is part of EGT, for more than 10 years already. The agreement allows MoBiTec to also offer EGT's state-of-the-art qPCR kits, oligonucleotides, and further products related to genomics to its customers. - August 14, 2015 - MoBiTec GmbH

KinderPharm Raises $1 Million to Further Advance Pediatric Drug Development

KinderPharm, a full-service contract research organization (CRO) dedicated exclusively to pediatric drug development, has raised $1 million from a Series A comprised of individuals, companies and angel investors. The $1 million investment will be used to further advance the clinical development of new medicines for children. - August 13, 2015 - KinderPharm LLC

ABR Launches Bovine Polyomavirus Testing Service

ABR (now a VMRD division) announced today the availability of a new testing service that can detect the presence of bovine polyomavirus (BPyV) in animal origin products, master virus seeds, and other sample types. This infectivity assay, without using non-infectivity assays such as PCR, has the... - August 12, 2015 - VMRD, Inc.

ADC Contract Manufacturing Market: Opportunities Ahead

Antibody Drug Conjugates (ADCs) are a new class of therapeutic drugs consisting of a cytotoxic drug linked to a monoclonal antibody. These novel conjugates are believed to be very effective and efficient in treatment of a disease. However, manufacturing such highly potent toxic molecules is accompanied with several known and unknown challenges. - August 10, 2015 - Roots Analysis

Dr Nader N Youssef Appointed Chief Medical Officer of electroCore

Dr Nader N Youssef has been appointed Chief Medical Officer of electroCore, the US based electroceutical healthcare company. Nader brings more than 15 years of clinical, academic, and industry research experience to electroCore. He was previously Executive Director GI Global Clinical Development... - August 09, 2015 - electroCore

Pinnacle 21 CEO Max Kanevsky Named to PharmaVOICE 100

Pinnacle 21 announced today that its president & CEO, Max Kanevsky, has been named to the prestigious PharmaVOICE 100 list of the most innovative and influential people in the life-sciences industry. - August 07, 2015 - Pinnacle 21

The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor

The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor

AmnioChor is a biotech startup engaged in perinatal stem cell technologies, founded with a long term vision and operating on a near term mandate. The vision is the ability to satisfy the therapeutic needs of Mesenchymal and Epithelial stem cells as the critical high volume foundation of new cures. The immediate mandate is to create the bank to serve that need through the cryopreservation of the living amniotic membrane of the placental sac. - August 06, 2015 - AmnioChor

Vitamin Weed: Get Healthy, Not High: Big Brother Star Launches Crowdfunding Campaign for Cannabis Book

Dr. Michele Noonan Ross plans to educate both patients and doctors with her new book Vitamin Weed: Get Healthy, Not High, a revolutionary 4-step plan to reversing endocannabinoid deficiency and restoring balance to your body. Launching July 22nd on the Publishizer crowdfunding platform, 10% of book sales will be donated to the Endocannabinoid Deficiency Foundation to directly fund cannabinoid research. - August 06, 2015 - GreenStone Labs

Motorcyclists in Three States Help Children with Brain Tumors

Ride for Kids motorcyclists gathered in three states over the weekend and raised $103,927 for the Pediatric Brain Tumor Foundation. The events in Michigan, New York and Pennsylvania honored 25 local brain tumor survivors on Aug. 2: Andrea, Andrew, Angel, Annabelle, Bo, Catie, Gianna, James, Jon,... - August 05, 2015 - Pediatric Brain Tumor Foundation

Israel Patent Allowance for GH, IGF-1 and Obesity Vaccines to Braasch Biotech

Israel Patent Allowance for GH, IGF-1 and Obesity Vaccines to Braasch Biotech

Israel Patent Office allows patent for treatment of hormone deficiencies and obesity in humans and pets. - August 01, 2015 - Braasch Biotech LLC

Riders in Midwest, South Raise Funds for the PBTF

From the southern hills to the Midwestern plains, Ride for Kids motorcyclists combined to raise more than $90,000 for the Pediatric Brain Tumor Foundation on July 26. More than 300 participants attended the East Tennessee and Kansas City Ride for Kids events to honor their local brain tumor... - July 29, 2015 - Pediatric Brain Tumor Foundation

Fannin Innovation Studio Expands Team as Life Science Portfolio Grows

Dr. Michael Heffernan to lead R&D of novel biomedical technologies. - July 29, 2015 - Fannin Partners, LLC

New Technology from MR Solutions Could Mean That Our Children Can Still Have Helium Party Balloons in the Future

Helium filled party balloons could be relegated to the past if the supply of helium dwindles, but MR Solutions, the world technology leader in preclinical MRI systems could be riding to the rescue with scanners that do not require liquid helium. - July 25, 2015 - MR Solutions

Press Releases 901 - 950 of 3,209